Skip to main content
. 2018 May 22;9(39):25474–25490. doi: 10.18632/oncotarget.25312

Table 6. Multivariate analysis of prognostic factors for SAR.

Location Colon cancer Rectal cancer
Stage Stage II Stage III Stage II Stage III
Factors HR
CI
P HR
CI
P HR
CI
P HR
CI
P
Age:
 75≤
2.71
1.56-4.67
0.0005 1.33
0.93-1.9
NS 1.77
0.81-3.56
NS 1.78
1.03-2.96
0.04
Gender:
 Female
1.69
1.14-2.47
0.009
CEA:
 High
2.33
1.34-4.11
0.003
Histological type:
 Poorly/Mucinous
2.04
1.15-3.41
0.02 2.54
1.34-4.54
0.005
Tumor depth:
 T4
1.42
0.84-2.43
NS 1.32
0.93-1.87
NS
Nodal status:
 N2
1.5
1.05-2.12
0.03
Lymphatic invasion:
 ly3
1.23
0.66-2.15
NS
Recurrence:
 within 1 year
1.64
1.12-2.4
0.01
Type of recurrence:
 M1b
2.50
1.25-4.83
0.01 1.39
0.84-2.18
NS 2.69
1.31-5.25
0.008 1.68
0.97-2.78
NS
Recurrence sites
 Liver (+) 1.04
0.58-1.84
NS
 Lung: (+) 1.25
0.68-2.24
NS
 Peritoneal: (+) 0.74
0.35-1.61
NS 1.37
0.82-2.36
NS 1.11
0.53-2.27
NS
 Local: (+) 3.54
1.5-7.69
0.005
No adjuvant therapy 1.00
0.64-1.53
NS
No surgical resection after recurrence 5.0
2.73-9.45
<0.0001 2.36
1.64-3.43
<0.0001 3.41
1.93-6.18
<0.0001 4.03
2.65-6.25
<0.0001

CEA: Carcinoembryonic antigen, CI: confidence interval, HR: hazard ratio, Mucinous: mucinous adenocarcinoma, NS: Not significant, Poorly: poorly differentiated adenocarcinoma, SAR: survival after recurrence.